highgreennews

Latest posts

Cannabis giants, formerly of Canopy Growth, band together to build out U.S. hemp supply chain

Three titans of the North American hemp industry announced Monday that they had joined forces to build out the U.S. hemp supply chain.

Geoff Whaling is the Pennsylvania-based chairman of the National Hemp Association who is credited with launching the first Hemp Industrial Park in the Southern Tier of New York State.

Bruce Linton is the founder and former CEO of Canopy Growth Corp. (CGC), the world’s largest cannabis company and the first marijuana firm to be listed on the New York Stock Exchange.

Medical cannabis import restrictions lifted for UK patients

Medical cannabis patients in the UK will now have faster access to their prescriptions thanks to new changes on import restrictions.

The UK government has now approved changes to import restrictions to ensure that people with prescriptions for cannabis-based products for medical use do not have their treatment delayed or interrupted.

New Law Brings Texas One Step Closer to Legalizing Marijuana

The blossoming medicinal cannabis market gets a boost from Texas lawmakers.

Texas is one step closer to joining the 34 states where medicinal marijuana is legal after state legislators passed a law written by North Texas Republican representative and registered nurse Stephanie Klick to expand the conditions that can be treated with medicinal cannabis.  Although the law narrowly defines which conditions can be treated with medicinal marijuana, it is a significant expansion. 

Canada to Offer 'Value' Marijuana Brands to Compete With Illegal Sellers Market

Canadian cannabis companies are introducing lower-priced, "value brand" marijuana in a bid to overtake sellers on the illegal market, who reportedly account for nearly 70 percent of the country's total cannabis sales.

Recreational marijuana was legalized in Canada under the Cannabis Act, which has been in effect from October 2018. Canada is the second country in the world to legalize cannabis for recreational use nationwide after Uruguay.

California’s First Year of Legal Cannabis Sales Brought Increased Demand, Especially Among Seniors

Cannabis retailer Eaze released its fifth annual insight report earlier this month detailing some of the major consumer trends in cannabis. The results are based entirely on sales from Eaze’s platform, so they are biased in that way, but they also offer a bit of insight into what the consumer cannabis market looks like right now, at least for online marketplaces.

Florida Senate moves to cap THC potency for medical marijuana

In a last-ditch effort at the tail end of the legislative session, the chamber most likely to oppose a cap on THC has taken up the issue.

After weeks of rumors that the Florida House was pushing an amendment that would put a cap on the amount of THC in all medical marijuana at 10% potency, the proposal was finally filed Friday afternoon in the Senate.

THC is the main psychoactive compound in marijuana, and can come in the form of whole-flower marijuana, tinctures, oils, vaporizers and edibles.

Will NFL Marijuana Policy Changes Be Enough for Players to Approve CBA?

Most headlines coming out of negotiations between NFL owners and players over the collective bargaining agreement (CBA) have focused on the proposed 17-game schedule. While that topic has been a main point of discussion, the league’s marijuana policy could play a role in whether or not the deal gets done.

Cannabis Compound Holds Hidden Antibiotic Properties

Could cannabis be a new weapon in the fight against antibiotic resistance? Scientists have discovered that cannabigerol (CBG), a non-psychoactive cannabis compound, holds some hidden antibiotic properties. 

Scientists from McMaster University in Canada found that CBG was effective against drug-resistant superbug infections in mice. In fact, it appeared to work just as well as vancomycin, a powerful antibiotic often used to treat superbugs. While it’s going to take a lot of fine-tuning, the compound could potentially be used in a new antibiotic treatment.